FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

11276611000001106: Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40588501000001117 Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
69338301000001110 Ranzac 75mg tablets (Boston Healthcare Ltd) 12 tablet 2 x 6 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets Is a Ranitidine 75mg tablets 12 tablet true Inferred relationship Existential restriction modifier
Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets Is pack of Ranzac 75mg tablets (L.P.C Medical) false Inferred relationship Existential restriction modifier
Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets Has active ingredient Ranitidine hydrochloride false Inferred relationship Existential restriction modifier
Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets Has active ingredient Ranitidine false Inferred relationship Existential restriction modifier
Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets Legal category General sales list true Inferred relationship Existential restriction modifier
Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets Has AMP Ranzac 75mg tablets (L.P.C Medical) true Inferred relationship Existential restriction modifier
Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets Has specific active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Ranzac 75mg tablets (LPC Medical (UK) Ltd) 12 tablet 2 x 6 tablets Has basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start